Dyne Therapeutics Inc (DYN)
23.65
-1.17
(-4.71%)
USD |
NASDAQ |
Apr 18, 16:00
23.64
-0.01
(-0.04%)
After-Hours: 20:00
Dyne Therapeutics Free Cash Flow: -188.89M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -188.89M |
| September 30, 2023 | -183.51M |
| June 30, 2023 | -176.43M |
| March 31, 2023 | -151.71M |
| December 31, 2022 | -156.71M |
| September 30, 2022 | -157.06M |
| June 30, 2022 | -141.20M |
| Date | Value |
|---|---|
| March 31, 2022 | -156.92M |
| December 31, 2021 | -123.18M |
| September 30, 2021 | -113.88M |
| June 30, 2021 | -98.09M |
| March 31, 2021 | -58.57M |
| December 31, 2020 | -47.67M |
Free Cash Flow Range, Past 5 Years
-188.89M
Minimum
Dec 2023
-47.67M
Maximum
Dec 2020
-134.91M
Average
-151.71M
Median
Mar 2023
Free Cash Flow Benchmarks
| Rocket Pharmaceuticals Inc | -211.39M |
| Solid Biosciences Inc | -95.70M |
| Avidity Biosciences Inc | -123.29M |
| Sana Biotechnology Inc | -273.61M |
| Tenaya Therapeutics Inc | -103.31M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -35.01M |
| Cash from Investing (Quarterly) | 26.20M |
| Cash from Financing (Quarterly) | 0.147M |
| Free Cash Flow Per Share (Quarterly) | -0.5714 |
| Free Cash Flow Yield | -13.38% |